Electronic signatures misused during system operation – risk-based ERES remediation


“`html

Published on 30/01/2026

Addressing Misuse of Electronic Signatures in System Operations: A Risk-Based Remediation Playbook

The increasing reliance on electronic records and electronic signatures (ERES) in the pharmaceutical industry brings significant regulatory benefits but also introduces risks, especially concerning data integrity. Instances of electronic signatures being misused during system operations can lead to compliance violations, jeopardizing regulatory submissions and inspection readiness. This article offers a comprehensive playbook for pharma professionals, equipping them to effectively identify, investigate, and remediate these issues.

By following this actionable guidance, teams across production, quality control (QC), quality assurance (QA), engineering, and regulatory affairs (RA) can ensure adherence to best practices in managing ERES while mitigating risks associated with misuse.

Symptoms/Signals on the Floor or in the Lab

Recognizing the early warnings of electronic signature misuse is crucial for effective intervention. Here are key symptoms and signals that can alert personnel to potential issues:

  • Unauthorized Access: Increasing trends in log-in attempts from non-licensed users.
  • Discrepancies in Signature Logs: Inconsistencies between
recorded signature actions and expected user behavior.
  • High Frequency of Signature Abandonment: A notable rate of signed but incomplete transactions or records.
  • Alice and Bob Scenario: Patterns indicating that users may be signing on behalf of others without authorization.
  • Audit Trail Anomalies: Unusual changes or gaps in the audit trails related to critical operations.
  • Likely Causes

    Understanding the potential causes behind the misuse of electronic signatures is essential for effective remediation. These causes can typically be categorized as follows:

    Category Likely Causes
    Materials Lack of proper documentation and adherence to GDP ALCOA+ principles, leading to confusion.
    Method Inconsistent operating procedures for system access and electronic signature utilization.
    Machine Malfunctioning software may lead to errors during signing or record creation.
    Man Insufficient training regarding protocols surrounding electronic signatures, resulting in misuse.
    Measurement Inaccurate user activity logs leading to misinterpretation of signing events.
    Environment Security vulnerabilities in network systems allowing unauthorized access points.

    Immediate Containment Actions (First 60 Minutes)

    Prompt action is vital once misuse is suspected. Here is a rapid response plan:

    • Notify Stakeholders: Inform QA, IT, and management of the potential misuse immediately.
    • Limit Access: Temporarily revoke user access to systems where the misuse is suspected until a full analysis can be performed.
    • Preserve Evidence: Ensure that all relevant logs, records, and digital trails are captured and secured for later review.
    • Document Initial Findings: Record the nature of the misuse, including who is believed to be involved, dates, and what systems were affected.
    • Coordinate with IT: Work with IT to investigate and disable potential unauthorized accesses or accounts.

    Investigation Workflow

    Begin the investigation by establishing a structured workflow:

    1. Data Collection: Gather all pertinent electronic records, security logs, and any related documentation. Ensure data integrity by following GDP ALCOA+ principles.
    2. Interviews: Conduct interviews with personnel who may have relevant insights. Document interactions thoroughly to capture context.
    3. Data Interpretation: Analyze the data against established operating procedures and signatory requirements.
    4. Review Access Control Logs: Identify patterns of unauthorized access and any attempts to bypass systems.
    5. Convene an Investigation Team: Form a multidisciplinary team to review findings collaboratively, ensuring diverse perspectives are integrated.

    Root Cause Tools: 5-Why, Fishbone, Fault Tree Analysis

    Establishing the root cause of electronic signature misuse requires systematic approaches:

    • 5-Why Analysis: Ideal for understanding deeper issues; begin with “Why did this occur?” and continue to ask “Why?” to each subsequent answer until root causes surface.
    • Fishbone Diagram: Best utilized for visualizing potential causes under major categories. Use during team brainstorming to identify additional root causes in a collaborative environment.
    • Fault Tree Analysis: Effective for complex systems, guiding the investigation down through contributing factors to identify systemic weaknesses.

    CAPA Strategy

    Addressing the findings through a robust Corrective and Preventive Action (CAPA) plan is critical:

    • Correction: Immediate fix of any misused electronic signatures, including formal warnings and re-training if required.
    • Corrective Action: Implement procedural improvements, such as enhanced training on electronic signature policies, and adjustments to access controls.
    • Preventive Action: Regular audits of systems, reviews of access logs, and ongoing training scheduled to ensure all personnel are up to date on compliance requirements.

    Control Strategy & Monitoring

    Establish control mechanisms to monitor electronic signatures actively:

    • Statistical Process Control (SPC): Utilize SPC charts to visualize trends in user activity and detect anomalies quickly.
    • Sampling: Implement sampling strategies for thorough examination of signature logs and operating procedures.
    • Alarms and Alerts: Configure system alarms for abnormal login attempts or suspicious modifications to records.
    • Verification Processes: Regular checks of compliance with ERES guidelines during operations and batch reviews to ensure integrity.

    Validation / Re-qualification / Change Control Impact

    Consider the impact of electronic signature misuse on validation and change control processes:

    • Validation Impact: Assess whether the misuse has compromised the validation status of affected systems and processes.
    • Re-qualification Requirements: Identify if any activities require re-qualification due to unauthorized signatures.
    • Change Control Procedures: Review any changes made during the misuse that require changes to be formally documented and evaluated for compliance.

    Inspection Readiness: What Evidence to Show

    Preparation for a potential inspection following an incident of electronic signature misuse includes a thorough compilation of evidence:

    • Records: Maintain up-to-date records of all signatory actions taken, related to the systems affected.
    • Logs: Keep detailed logs of user activity that include dates, actions taken, and who performed them.
    • Batch Documentation: Ensure that all batch production records are intact and reflect accurate signing processes.
    • Deviations: Document all deviations related to electronic signatures, along with associated investigations and CAPA outcomes.

    FAQs

    What are the best practices for maintaining electronic signature integrity?

    Implement regular training, comprehensive documentation, and robust security protocols to ensure integrity is maintained.

    Related Reads

    How can one verify an electronic signature?

    Verification can typically be achieved through audit trails that confirm who signed, when, and from which device.

    What steps should be taken if an unauthorized signature is discovered?

    Immediately notify stakeholders, investigate thoroughly, and take corrective actions as outlined in your CAPA plan.

    How often should training on electronic signatures be conducted?

    Training should occur regularly, annually at a minimum, or whenever changes to procedures or systems occur.

    What regulatory standards govern electronic signatures in pharmaceuticals?

    Regulatory standards include FDA 21 CFR Part 11 in the US and various guidelines from EMA and MHRA regarding ERES compliance.

    How can statistical process control (SPC) improve electronic signature monitoring?

    SPC provides a quantitative measure of signatures over time, allowing for the detection of anomalies or trends indicative of potential misuse.

    What documentation is essential for compliance audits related to ERES?

    Key documents include electronic records, audit logs, training records, and CAPA documentation related to electronic signatures.

    How can Fishbone diagrams assist in risk assessments?

    Fishbone diagrams help systematically identify potential causes of issues during risk assessments, highlighting contributing factors.

    Why is it critical to preserve evidence immediately after identifying misuse?

    Preserving evidence ensures that data integrity is maintained for investigation, compliance, and audit purposes.

    Can unauthorized electronic signatures affect product recalls?

    Yes, unauthorized signatures can compromise product integrity and traceability, complicating recall processes.

    What role does IT play in managing electronic signature misuse?

    IT is crucial for monitoring system access, securing data through cybersecurity measures, and providing technical support during investigations.

    How can we ensure compliance during system upgrades or changes?

    Implement a robust change control process that includes revision of training, re-validation, and documentation updates to maintain compliance.

    Pharma Tip:  Record retention failures during system operation – CAPA and revalidation strategy